Financing and expanded board leadership position the company to accelerate FDA clearance and commercialization of its novel imaging system

融资和扩大董事会领导层使公司能够加速其新型成像系统的FDA审批和商业化进程。

SUNNYVALE, Calif. and GIVATAYIM, Israel

加利福尼亚州桑尼维尔和以色列吉瓦塔伊姆

,

，

May 18, 2026

2026年5月18日

/PRNewswire/ --

/PRNewswire/ --

Vortex Imaging Inc.

涡旋成像公司

announced today the closing of a $12 million financing round, supported by existing and new investors, including 10D Ventures, Entrée Capital, Harel T.E.C Partnership, Connecticut Innovations, and PhiFund Ventures.

今天宣布完成了1200万美元的融资回合，得到了现有投资者和新投资者的支持，包括10D Ventures、Entrée Capital、Harel T.E.C Partnership、Connecticut Innovations和PhiFund Ventures。

The financing will support the continued development, regulatory clearance, and market launch of Vortex Imaging's computational ultrasound system, a novel imaging technology designed to enable high-quality 3D volumetric imaging at the point of care using pioneering computational image reconstruction technology, utilizing GPUs-on-Cloud..

这笔融资将支持Vortex Imaging的计算超声系统持续开发、监管审批和市场发布，该系统是一项创新的成像技术，旨在通过使用基于云端的GPU和开创性的计算图像重建技术，在护理点实现高质量的3D体积成像。

Today, many advanced imaging workflows rely on centralized radiology suites, which can contribute to delays in access to imaging and patient care. Vortex Imaging is developing a compact ultrasound-based imaging system designed to bring advanced 3D volumetric imaging into everyday clinical settings. The system aims to reduce variability associated with conventional ultrasound workflows by enabling standardized, reproducible volumetric datasets with a reduced learning curve, while avoiding ionizing radiation and large imaging infrastructure..

如今，许多先进的成像工作流程依赖于集中式的放射科套件，这可能会导致成像和患者护理的延迟。Vortex Imaging正在开发一种紧凑的基于超声波的成像系统，旨在将先进的3D体积成像引入日常临床环境。该系统旨在通过实现标准化、可重复的体积数据集来减少与传统超声工作流程相关的变异性，同时降低学习曲线，并避免电离辐射和大型成像基础设施的使用。

The reconstructed images are intended to provide physicians with advanced 3D volumetric visualization capabilities in a format traditionally associated with CT and MRI, while maintaining the accessibility, safety, and portability advantages of ultrasound.

重建的图像旨在为医生提供通常与CT和MRI相关的先进3D体积可视化功能，同时保留超声波的易用性、安全性和便携性优势。

'This financing round marks a major milestone for Vortex Imaging,' said Tomer Ben David, CEO of Vortex Imaging. 'Vortex is focused on transforming ultrasound from a highly operator-dependent modality into a standardized, volumetric imaging system capable of delivering advanced 3D clinical insights directly at the point of care.

“此轮融资标志着Vortex Imaging的一个重要里程碑，”Vortex Imaging首席执行官Tomer Ben David表示，“Vortex致力于将超声波从一种高度依赖操作者的模式转变为标准化的体积成像系统，能够在护理点直接提供先进的3D临床见解。”

We are excited to have the support of experienced investors and board members as we continue advancing toward FDA clearance and initial clinical deployment.'.

我们很高兴在继续朝着FDA批准和初步临床部署的过程中，得到有经验的投资者和董事会成员的支持。

In addition, Ori Hadomi, former CEO of Mazor Robotics and current Vice President of Strategic Initiatives & Partnerships at Medtronic, has been appointed Chairman of the Board, bringing significant experience in guiding transformative medical technologies from development to global commercialization..

此外，前Mazor Robotics首席执行官、现任美敦力战略计划与合作副总裁的Ori Hadomi被任命为董事会主席，他在指导变革性医疗技术从开发到全球商业化方面拥有丰富的经验。

The board will also include experienced healthcare and medtech leaders, including Chris Cleary, former Vice President of Corporate Development at Medtronic and former GE Healthcare executive; Yahal Zilka, co-founder and Managing Partner at 10D Ventures; and Dr. Yael Grunbaum, Partner at Entree Capital and Head of Entrée Bio..

董事会还将包括经验丰富的医疗保健和医疗技术领导者，包括前美敦力公司发展副总裁、前GE医疗高管克里斯·克利；10D Ventures的联合创始人兼管理合伙人亚哈尔·齐尔卡；以及Entree Capital的合伙人、Entree Bio负责人雅埃尔·格伦鲍姆博士。

Together, the expanded board brings deep expertise across medical imaging, strategic growth, corporate development, and commercialization of global medtech platforms.

扩大后的董事会共同带来了医学影像、战略增长、企业发展以及全球医疗技术平台商业化方面的深厚专业知识。

Vortex Imaging's initial clinical focus is on urology and nephrology, with broader future applications planned across additional diagnostic and procedural domains.

旋涡成像公司最初的临床重点是泌尿科和肾病科，并计划未来在更多的诊断和程序领域进行应用。

'Vortex Imaging has the potential to significantly expand how and where advanced imaging is performed,' said Ori Hadomi, Chairman of the Board. 'The combination of high-quality volumetric imaging, reduced operator dependency, and a compact ultrasound-based platform could enable a far more scalable and standardized approach to imaging across healthcare systems.'.

“涡旋成像有潜力大幅扩展先进成像的实施方式和应用场景，”董事会主席奥里·哈多米表示。“高质量体积成像、操作依赖性降低以及基于紧凑型超声波平台的结合，可能会在医疗系统中实现更易扩展且标准化的成像方法。”

For more information visit:

访问以下网址以获取更多信息：

https://www.vortex-imaging.com/

https://www.vortex-imaging.com/

or

或

LinkedIn

领英

.

。

Watch:

观察：

Why wait for imaging?

为什么等待成像？

Contact:

联系人：

Izik Ithakov

伊齐克·伊萨科夫

[email protected]

电子邮件地址

SOURCE Vortex Imaging Inc.

来源：涡旋成像公司

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示